Beat AML: Personalized Medicine for Acute Myeloid Leukemia Based on Functional Genomics

Purpose

The purpose of this study is to profile AML cancer cell molecular diagnostics and patient pharmacogenetics to simulate cancer cell function and screen for FDA approved drugs with anti-neoplastic activity and predict adverse events to prescribed treatments.

Keywords

Acute myeloid leukemia, Leukemia, Leukemia - resources

Principal Investigator

Christopher R Cogle, M.D.

Department

MD-HEMATOLOGY/ONCOLOGY

Contact Information

Christopher.Cogle@medicine.ufl.edu

3522737493


Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • HealthStreet: Health-focused services, classes and events, and opportunities to participate in research.
  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams